Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
08/29/2012 | CN102000330B Nucleic acid vaccine adjuvant and construction method thereof |
08/29/2012 | CN101979549B Gene medicament taking voltage-gated proton channel Hv1 as targeted locus for treatment of breast cancer |
08/29/2012 | CN101940786B Application of immunogenic protein gene PilA of haemophilus parasuis |
08/29/2012 | CN101928345B Human source antibody and humanization remolding method thereof |
08/29/2012 | CN101240271B Toll-like receptor adjustment oligonucleotide and use thereof |
08/29/2012 | CN101163796B Cationic lipids and methods of use |
08/29/2012 | CN101028519B Pharmaceutical composition for treating immune diseases |
08/28/2012 | US8252765 Treatment of cancer by inhibition of IGFBPs and clusterin |
08/28/2012 | US8252763 RNAi therapeutic for treatment of hepatitis C infection |
08/28/2012 | US8252761 Method of increasing murine ES cell differentiation with PCL2 |
08/28/2012 | US8252756 Nucleic acid functionalized nanoparticles for therapeutic applications |
08/28/2012 | US8252755 Sense strand, antisense strand having complementarity to both the sense strand and a target gene, forming a duplex, a conjugate, facilitating cellular delivery, and a linker molecule; facilitates delivery to a cell, tissue or organism |
08/28/2012 | US8252537 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy |
08/28/2012 | US8252277 Virulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
08/28/2012 | CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels |
08/28/2012 | CA2454073C Mutations in ion channels |
08/28/2012 | CA2450470C Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
08/28/2012 | CA2445578C Biological pacemaker comprising dominant-negative kir2.1aaa |
08/28/2012 | CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof |
08/23/2012 | WO2012112832A1 Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer |
08/23/2012 | WO2012112696A1 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells |
08/23/2012 | WO2012112578A2 Improved aav8 vector with enhanced functional activity and methods of use thereof |
08/23/2012 | WO2012109798A1 Hbv treatment |
08/23/2012 | WO2012091496A3 siRNA FOR INHIBITION OF Hif1α EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME |
08/23/2012 | WO2012061443A3 Compositions of a peptide targeting system for treating cancer |
08/23/2012 | WO2012012541A3 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
08/23/2012 | WO2010030751A9 New modalities for treatment of drug-resistant tuberculosis and other diseases |
08/23/2012 | US20120214867 Bacteriophage T4 Nanoparticles for Eukaryotic Delivery |
08/23/2012 | US20120214866 Treatment with cytokines |
08/23/2012 | US20120214742 Gaba release-regulating agent in cerebellum |
08/23/2012 | US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2 |
08/23/2012 | US20120213848 Treatment of Infection Using Single Chain Antibody Gene Therapy |
08/23/2012 | US20120213815 Vaccines and immunotherapeutics using codon-optimized il-15 and methods for using the same |
08/23/2012 | US20120213778 Method of detecting and treating tuberous sclerosis complex associated disorders |
08/23/2012 | US20120213777 Vascular endothelial growth factor 2 |
08/23/2012 | US20120213752 Isolated stromal cells and methods of using the same |
08/23/2012 | US20120213749 Cardiac muscle regeneration using mesenchymal stem cells |
08/23/2012 | US20120213738 Cardiac Repair By Reprogramming of Cardiac Fibroblasts Into Cardiomyocytes |
08/23/2012 | US20120213731 Methods and compositions for treating autoimmune diseases |
08/23/2012 | CA2827645A1 Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug related applications |
08/23/2012 | CA2827443A1 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells |
08/23/2012 | CA2827375A1 Improved aav8 vector with enhanced functional activity and methods of use thereof |
08/23/2012 | CA2826316A1 Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer |
08/22/2012 | EP2489737A1 Interfering RNA duplex having blunt-ends and 3'-modifications |
08/22/2012 | EP2489733A2 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders |
08/22/2012 | EP2489366A1 Use of spink6 gene and protein encoded therein in the manufacture of anti-tumor medicaments |
08/22/2012 | EP2489348A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
08/22/2012 | EP2488641A2 Supercoiled minicircle dna for gene therapy applications |
08/22/2012 | EP2488165A1 Nanoparticle of the core-shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular dystrophy |
08/22/2012 | EP1651050B1 Acellular tissue matrices made from galactose alpha-1,3-galactose -deficient tissue |
08/22/2012 | EP1649028B1 Adenoviral vector-based vaccines |
08/22/2012 | EP1584623B1 A group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof |
08/22/2012 | CN1909918B T cell immunoreaction inhibitor |
08/22/2012 | CN102648004A Photosensitizing compositions |
08/22/2012 | CN102643858A Efficiently-replicated human hepatitis B virus recombinant vector and application thereof |
08/22/2012 | CN102643854A Eukaryon recombinant plasmid, preparation process and applications thereof |
08/22/2012 | CN102643822A Heartworm nucleic acid vaccine and method for preparing same |
08/22/2012 | CN102643819A ShRNA of Rab23 and ientiviral vector and applications thereof |
08/22/2012 | CN102643818A Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases |
08/22/2012 | CN102643814A Antisense oligonucleotide for human miR-431 and application thereof |
08/22/2012 | CN102643813A Human miR-504 antisense oligonucleotide and application thereof |
08/22/2012 | CN102643812A Human miR-1227 antisense oligonucleotide and application thereof |
08/22/2012 | CN102643811A Human miR-1229 antisense oligonucleotide and application thereof |
08/22/2012 | CN102643810A Human miR-299-5p antisense oligonucleotide and application thereof |
08/22/2012 | CN102643809A Antisense oligodeoxyncleotide of human miR-1274b and application thereof |
08/22/2012 | CN102643808A Antisense oligodeoxyncleotide of human miR-1539 and application thereof |
08/22/2012 | CN102643807A Antisense oligodeoxyncleotide of human miR-484 and application thereof |
08/22/2012 | CN102643806A Antisense oligodeoxyncleotide of human miR-1913 and application thereof |
08/22/2012 | CN102643785A Method for targeted inhibition of infiltration and transfer of glioma cells and application of method |
08/22/2012 | CN102643343A Human derived anti-rabies virus glycoprotein gene engineering antibody and preparation and application thereof |
08/22/2012 | CN102641509A Application of Epstein barr (EB) virus miR-BART7 antisense oligonucleotide in preparing medicine capable of treating nasopharynx cancer |
08/22/2012 | CN102641508A Application of target up-regulation PAR-4 gene small ribonucleic acid (RNA) in preparing bladder cancer resisting drugs |
08/22/2012 | CN102641503A Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
08/22/2012 | CN102641499A Construction and application of recombinant Peste des petits ruminants virus (PPRV) live vector vaccine for foot and mouth disease virus (FMDV) VP1 gene |
08/22/2012 | CN102051358B Mosaic tumor specific gene expression regulation kit and application thereof |
08/22/2012 | CN101429236B Type II non-structural protein 2B of dengue virus, recombinant expression vector, preparation and uses thereof |
08/22/2012 | CN101063142B Human papilloma virus 16 type DNA vaccine and gene adjuvant and its application |
08/21/2012 | US8247544 Method for producing a cell and/or tissue and/or disease phase specific medicament |
08/21/2012 | US8247388 Role of miRNA in T cell leukemia |
08/21/2012 | US8247385 Treatment and prevention of neurodegenerative diseases using gene therapy |
08/21/2012 | US8247384 Methods and compositions for wound healing |
08/21/2012 | US8246948 Stimulation of cartilage formation using reduced pressure treatment |
08/21/2012 | CA2529179C Recombinant adeno-associated virus vector for treatment of alzheimer disease |
08/21/2012 | CA2478910C Methods and means for monitoring and modulating gene silencing |
08/21/2012 | CA2450206C Improved yield of chordopoxvirus by propagation at low temperature |
08/21/2012 | CA2362830C Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
08/16/2012 | WO2012109567A2 Treatment of angiogenesis disorders |
08/16/2012 | WO2012109469A2 Methods of treating alzheimer's disease with apo a-1 milano |
08/16/2012 | WO2012109363A2 Mucus penetrating gene carriers |
08/16/2012 | WO2012109329A2 Methods for treatment of melanoma |
08/16/2012 | WO2012109214A1 Targeted transduction of aav vectors |
08/16/2012 | WO2012109199A1 Neural transfection reagents |
08/16/2012 | WO2012108843A1 Treating cancer by inhibiting expression of olfm4, sp5, tobi, arjdia, fbni or hat1 |
08/16/2012 | WO2012108397A1 Novel lipid |
08/16/2012 | WO2012107073A1 Ubiad1 for cellular coenzyme q10 synthesis and cardiovascular oxidative protection |
08/16/2012 | WO2012075379A3 Liquid viral formulations |
08/16/2012 | WO2012075376A3 Lyophilized viral formulations |
08/16/2012 | WO2012071561A3 Anti-il-6 antibodies for the treatment of anemia |
08/16/2012 | WO2012071554A3 Anti-il-6 antibodies for the treatment of oral mucositis |
08/16/2012 | WO2012068456A3 Compositions and methods for treating obesity |